13 results on '"Niyonsenga, Theo"'
Search Results
2. Additional file 1 of A Validated Injury Surveillance and Monitoring Tool for Fast Jet Aircrew: Translating Sports Medicine Paradigms to a Military Population
- Author
-
Wallace, James, Osmotherly, Peter, Gabbett, Tim, Spratford, Wayne, Niyonsenga, Theo, and Newman, Phil
- Abstract
Additional file 1: Delphi participant characteristics; Domains used to determine severity that participants felt overlapped so much they should be combined; the UC-FJAMQ; Within and between-individuals correlation matrices; and Factor loadings for within- and between-individuals analyses.
- Published
- 2022
- Full Text
- View/download PDF
3. Associations between young caring and mental health: a prospective observational study using augmented inverse probability treatment weighting
- Author
-
Mohanty, Itismita and Niyonsenga, Theo
- Subjects
Commentary - Published
- 2021
4. Additional file 1 of The knowledge of danger signs of obstetric complications among women in rural India: evaluating an integrated microfinance and health literacy program
- Author
-
Ahmad, Danish, Itismita Mohanty, Avishek Hazra, and Niyonsenga, Theo
- Abstract
Additional file 1. Shows the survey questionnaire utilised for data collection from eligible woman.
- Published
- 2021
- Full Text
- View/download PDF
5. Additional file 1 of A multilevel mixed effects analysis of informal carers health in Australia: the role of community participation, social support and trust at small area level
- Author
-
Mohanty, Itismita, Niyonsenga, Theo, Cochrane, Tom, and Rickwood, Debra
- Subjects
Data_FILES - Abstract
Additional file 1.
- Published
- 2020
- Full Text
- View/download PDF
6. Local Retail Destinations and Middle-to-Older Adults’ Mobility Decline
- Author
-
Takemi Sugiyama, Niyonsenga, Theo, Neil Coffee, and Daniel, Mark
7. 10-year assessment of predictive relationships between different dimensions of urban environments and incidents cardio-metabolic risk in South Australia
- Author
-
Daniel, Mark, Niyonsenga, Theo, Neil Coffee, Howard, Natasha J., Catherine Paquet, and Taylor, Anne W.
8. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: A randomized controlled trial (HELFIMED)
- Author
-
Catherine Itsiopoulos, Natalie Parletta, Bernhard T. Baune, Kerin O'Dea, Barbara J. Meyer, Svetlana Bogomolova, Anthony Villani, Jihyun Cho, Dorota Zarnowiecki, Sarah Blunden, Amy L. Wilson, Theo Niyonsenga, Leonie Segal, Parletta, Natalie, Zarnowiecki, Dorota, Cho, Jihyun, Wilson, Amy, Bogomolova, Svetlana, Villani, Anthony, Itsiopoulos, Catherine, Niyonsenga, Theo, Blunden, Sarah, Meyer, Barbara, Segal, Leonie, Baune, Bernhard T, and O'Dea, Kerin
- Subjects
Male ,Mediterranean diet ,Medicine (miscellaneous) ,Diet, Mediterranean ,fish oil ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,Quality of life ,law ,Medicine ,030212 general & internal medicine ,intervention ,Depression (differential diagnoses) ,Uncategorized ,2. Zero hunger ,Nutrition and Dietetics ,Depression ,General Neuroscience ,food and beverages ,General Medicine ,Middle Aged ,Fish oil ,3. Good health ,Mental Health ,Treatment Outcome ,Diet quality ,depression ,Female ,omega-3 ,mental health ,Adult ,Adolescent ,omega-6 ,03 medical and health sciences ,Young Adult ,Fish Oils ,Intervention (counseling) ,Environmental health ,Fatty Acids, Omega-6 ,Fatty Acids, Omega-3 ,Humans ,Aged ,business.industry ,Mental health ,quality of life ,Dietary Supplements ,Quality of Life ,business ,030217 neurology & neurosurgery - Abstract
Objectives: We investigated whether a Mediterranean-style diet (MedDiet) supplemented with fish oil can improve mental health in adults suffering depression. Methods: Adults with self-reported depression were randomized to receive fortnightly food hampers and MedDiet cooking workshops for 3 months and fish oil supplements for 6 months, or attend social groups fortnightly for 3 months. Assessments at baseline, 3 and 6 months included mental health, quality of life (QoL) and dietary questionnaires, and blood samples for erythrocyte fatty acid analysis. Results: n = 152 eligible adults aged 18–65 were recruited (n = 95 completed 3-month and n = 85 completed 6-month assessments). At 3 months, the MedDiet group had a higher MedDiet score (t = 3.95, P < 0.01), consumed more vegetables (t = 3.95, P < 0.01), fruit (t = 2.10, P = 0.04), nuts (t = 2.29, P = 0.02), legumes (t = 2.41, P = 0.02) wholegrains (t = 2.63, P = 0.01), and vegetable diversity (t = 3.27, P < 0.01); less unhealthy snacks (t = −2.10, P = 0.04) and red meat/chicken (t = −2.13, P = 0.04). The MedDiet group had greater reduction in depression (t = −2.24, P = 0.03) and improved mental health QoL scores (t = 2.10, P = 0.04) at 3 months. Improved diet and mental health were sustained at 6 months. Reduced depression was correlated with an increased MedDiet score (r = −0.298, P = 0.01), nuts (r = −0.264, P = 0.01), and vegetable diversity (r = −0.303, P = 0.01). Other mental health improvements had similar correlations, most notably for increased vegetable diversity and legumes. There were some correlations between increased omega-3, decreased omega-6 and improved mental health. Discussion: This is one of the first randomized controlled trials to show that healthy dietary changes are achievable and, supplemented with fish oil, can improve mental health in people with depression. Refereed/Peer-reviewed
- Published
- 2023
- Full Text
- View/download PDF
9. A Longitudinal Analysis of Mental and General Health Status of Informal Carers in Australia
- Author
-
Theo Niyonsenga, Itismita Mohanty, Mohanty, Itismita, and Niyonsenga, Theo
- Subjects
Adult ,Male ,Gerontology ,medicine.medical_specialty ,Adolescent ,Health Status ,health care facilities, manpower, and services ,health behaviour and informal carers age ,General health ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Surveys and Questionnaires ,Epidemiology ,Informal carers health ,Humans ,Medicine ,Longitudinal Studies ,030212 general & internal medicine ,Socioeconomic status ,health care economics and organizations ,Aged ,Retrospective Studies ,Aged, 80 and over ,informal carers health ,business.industry ,lcsh:Public aspects of medicine ,Health behaviour and informal carers age ,030503 health policy & services ,Public health ,Australia ,Public Health, Environmental and Occupational Health ,lcsh:RA1-1270 ,social sciences ,Middle Aged ,Mental health ,humanities ,general health ,Mental Health ,Caregivers ,Drinking Status ,Workforce ,Female ,Biostatistics ,0305 other medical science ,business ,mental health ,Research Article - Abstract
Background The study investigated the self-assessed mental and general health status of informal carers in Australia. It evaluated the influence of carer’s health behaviours, namely physical activity, smoking and drinking status, along with their social connectedness and workforce engagement on their health status. Methods The study used a retrospective longitudinal design using data from the Household Income and Labour Dynamics of Australia survey, waves 5–15 (2005–2015). It included individuals aged 15 years and older from Australian households surveyed over a period of 11 years. The sample consisted of 23,251 individuals. The outcome measures included: mental health, general health and physical functioning domains of the Short Form 36 Questionnaire, a widely used multi-dimensional measure of health-related quality of life. Using fixed effects regression and following individuals over time, the analysis took care of the issue of individuals self-selecting themselves as carers due to some predisposing factors such as age, poor health, socioeconomic status and sedentary behaviour. Results There were statistically significant carer-noncarer status differences in mental (Beta = − 0.587, p = 0.003) and general health (Beta = − 0.670, p = 0.001) outcomes. Aging had a modifying impact on carers’ mental and general health outcomes. Older carers coped better with their caregiving responsibilities than younger ones. Moreover, while physical activities had a positive influence on both mental and general health for non-carers, with more activities generating better health outcomes, it only had a modifying impact on carers’ mental health. Furthermore, the study found that moderate levels of social drinking had beneficial modifying impact on carers’ mental and general health. Conclusion This study added value to the literature on informal carers’ mental and general health in Australia by identifying some of the protective and risk factors. The study found the modifying effects of carers’ age, health behaviours such as physical activity, smoking and drinking status on their health. Finally, the study identified an apparent beneficial link between moderate levels of social drinking and carer health that needs to be further explored with more targeted future research.
- Published
- 2019
10. Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
- Author
-
David Roder, Theo Niyonsenga, Agnes Vitry, Huah Shin Ng, Bogda Koczwara, Ng, Huah Shin, Koczwara, Bogda, Roder, David, Niyonsenga, Theo, and Vitry, Agnes
- Subjects
Oncology ,medicine.medical_specialty ,medicine.drug_class ,lcsh:Medicine ,comorbidities ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Internal medicine ,Epidemiology of cancer ,Epidemiology ,medicine ,030212 general & internal medicine ,hormone-dependent breast cancer ,Aromatase inhibitor ,tamoxifen ,endocrine therapy ,business.industry ,Incidence (epidemiology) ,lcsh:R ,Cancer ,medicine.disease ,030220 oncology & carcinogenesis ,aromatase inhibitor ,Original Article ,business ,Tamoxifen ,cancer epidemiology ,Cohort study ,medicine.drug - Abstract
Background The development of comorbidities has become increasingly relevant with longer-term cancer survival. Objective To assess the pattern of comorbidities among Australian women with breast cancer treated with tamoxifen or an aromatase inhibitor. Design Retrospective cohort study using Pharmaceutical Benefits Scheme (PBS) data (10% sample) from January 2003 to December 2014. Dispensing claims data were used to identify comorbidities and classified with the Rx-Risk-V model. The breast cancer cohort had tamoxifen or an aromatase inhibitor dispensed between 2004 and 2011 with no switching between types of endocrine therapy. Comparisons were made between the breast cancer cohort and specific control groups (age- and sex-matched at 1:10 ratio without any dispensing of anti-neoplastic agents during the study period) for the development of five individual comorbidities over time using Cox regression models. Results Women treated with tamoxifen had a higher incidence of cardiovascular conditions, diabetes, and pain or pain-inflammation, but a lower incidence of hyperlipidaemia compared with non-cancer control groups, as indicated by PBS data. Women treated with aromatase inhibitors were more likely to develop cardiovascular conditions, osteoporosis, and pain or pain-inflammation compared with non-cancer control groups. The risks of hyperlipidaemia and osteoporosis were significantly lower among tamoxifen users compared with aromatase inhibitor users. Conclusions Women with hormone-dependent breast cancer treated with an endocrine therapy had a higher risk of developing specified comorbid conditions than women without cancer, with different comorbidity profiles for those on tamoxifen versus aromatase inhibitors. Further research into the causes and mechanism of development and management of comorbidities after cancer is needed.
- Published
- 2018
11. Comorbidities in Australian women with hormone‐dependent breast cancer: a population‐based analysis
- Author
-
Huah Shin Ng, Theo Niyonsenga, David Roder, Bogda Koczwara, Agnes Vitry, Ng, Huah Shin, Koczwara, Bogda, Roder, David M, Niyonsenga, Theo, and Vitry, Agnes I
- Subjects
medicine.medical_specialty ,Antineoplastic Agents, Hormonal ,Osteoporosis ,Breast Neoplasms ,Comorbidity ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,hormone-dependent breast cancer ,Depression (differential diagnoses) ,Aged ,Retrospective Studies ,Aged, 80 and over ,endocrine therapy ,Depression ,business.industry ,Hazard ratio ,Australia ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Cardiovascular Diseases ,030220 oncology & carcinogenesis ,Chronic Disease ,Female ,business ,Cohort study - Abstract
Objective: To compare how frequently selected chronic diseases developed in women with breast cancer receiving endocrine therapy, and in women without cancer. Design, setting and participants: Retrospective, rolling cohort study, analysing a random 10% sample of Pharmaceutical Benefits Scheme (PBS) data for the period 1 January 2003 – 31 December 2014. Women with breast cancer who first commenced endocrine therapy between January 2004 and December 2011 were identified, and age- and sex-matched (1:10) by comorbidity with control groups of women who did not have a dispensing record for antineoplastic agents during the study period or the comorbidity of interest at baseline. Main outcome measures: Development of any of eight pre-selected comorbidities, identified in PBS claims data with the RxRisk-V model. Results: Women with hormone-dependent breast cancer were significantly more likely than women in the control group to develop depression (overall hazard ratio [HR], 1.36; 95% CI, 1.26–1.46), pain or pain–inflammation (HR, 1.30; 95% CI, 1.23–1.38), osteoporosis (overall HR, 1.27; 95% CI, 1.17–1.39), diabetes (HR, 1.24; 95% CI, 1.10–1.41), cardiovascular disorders (overall HR, 1.22; 95% CI, 1.13–1.32), and gastric acid disorders (HR, 1.20; 95% CI, 1.13–1.28). The hazard ratios for developing cardiovascular disorders, depression and osteoporosis were highest during the first year of endocrine therapy. The risk of hyperlipidaemia was lower among women with breast cancer than in the control group (HR, 0.88; 95% CI, 0.81–0.96). There was no significant difference between the two groups in the risk of reactive airway diseases (HR, 1.05; 95% CI, 0.98–1.13). Conclusion: Comorbid conditions are more likely to develop in women who have been diagnosed with hormone-dependent breast cancer than in women without cancer. Our results further support the need to develop appropriate models of care to manage the multiple chronic disorders of breast cancer survivors. Refereed/Peer-reviewed
- Published
- 2018
12. Optimizing the measurement of comorbidity for a South Australian colorectal cancer population using administrative data
- Author
-
Elizabeth Buckley, Lettie Pule, David Roder, Theo Niyonsenga, Pule, Lettie, Buckley, Elizabeth, Niyonsenga, Theo, and Roder, David
- Subjects
Predictive validity ,medicine.medical_specialty ,Index (economics) ,Population ,colorectal cancer ,Comorbidity ,survival ,03 medical and health sciences ,Epidemiology ,South Australia ,Medicine ,Humans ,education ,education.field_of_study ,business.industry ,030503 health policy & services ,Health Policy ,Confounding ,Public Health, Environmental and Occupational Health ,Australia ,prediction models ,medicine.disease ,Prognosis ,comorbidity ,Brier score ,0305 other medical science ,business ,Colorectal Neoplasms ,Predictive modelling ,Demography - Abstract
Rationale and objectives: In epidemiological research, it is essential to account for the confounding effects of factors such as age, stage, and comorbidity for accurate prediction of cancer outcomes. There are several internationally developed and commonly used comorbidity indices. However, none are regarded as the gold-standard method. This study will assess and compare the predictive validity of established indices for use in a South Australian (SA) colorectal cancer (CRC) population against a local index. Furthermore, the prognostic influence of comorbidity on survival is investigated. Methods: A population-based study of patients diagnosed with CRC from 2003 to 2012 and linked to in-hospital data to retrieve comorbidity information was conducted. The predictive performance of established indices, Charlson comorbidity index (CCI), National Cancer Institute comorbidity index (NCI), Elixhauser comorbidity index (ECI), and C3 index was evaluated using the Fine and Gray competing risk regression and reported using measures of calibration and discrimination, area under the curve (AUC), and Brier score. Furthermore, to identify the optimal index, a local CRC comorbidity index (CRCCI) was also developed and its performance compared with the established indices. Results: Comorbidity models adjusted for age, sex, and stage showed that all indices were good predictors of mortality as measured by the AUC (CCI: 0.738, NCI: 0.742, ECI: 0.733, C3: 0.739). CRCCI had similar mortality prediction as established indices (CRCCI: 0.747). There was a significant increase in cumulative risk of noncancer and CRC-specific mortality with increase in comorbidity scores. The two most prevalent comorbidities were hypertension and diabetes. Conclusions: The existing indices are still valid for adjusting for comorbidity and accurately predicting mortality in an SA CRC population. Internationally developed indices are preferred when policymakers and researchers wish to compare local study results with those of studies (national and international) that have used these indices. Comorbidity is a predictor of mortality and should be considered when assessing CRC survival Refereed/Peer-reviewed
- Published
- 2019
13. A 6-month randomised controlled trial investigating effects of Mediterranean-style diet and fish oil supplementation on dietary behaviour change, mental and cardiometabolic health and health-related quality of life in adults with depression (HELFIMED): study protocol
- Author
-
Natalie Parletta, Kerin O'Dea, Catherine Itsiopoulos, Theo Niyonsenga, Barbara J. Meyer, Dorota Zarnowiecki, Anthony Villani, Jihyun Cho, Leonie Segal, Amy L. Wilson, Sarah Blunden, Svetlana Bogomolova, Zarnowiecki, Dorota, Cho, Jihyun, Wilson, Amy, Bogomolova, Svetlana, Villani, Anthony, Itsiopoulos, Catherine, Niyonsenga,Theo, O'Dea, Kerin, Blunden, Sarah, Meyer, Barbara, Segal, Leonie, and Parletta, Natalie
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Mediterranean diet ,Endocrinology, Diabetes and Metabolism ,Nutrition Education ,Medicine (miscellaneous) ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Randomized controlled trial ,law ,Environmental health ,medicine ,030212 general & internal medicine ,Depression (differential diagnoses) ,2. Zero hunger ,030109 nutrition & dietetics ,Nutrition and Dietetics ,DASS ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,Mental health ,3. Good health ,quality of life ,depression ,Physical therapy ,business ,cardiometabolic health ,study protocol ,Study protocol ,Cardiometabolic health ,Depression ,Quality of life - Abstract
Background: Modern diets, characterised by excess consumption of processed foods, are accompanied by an epidemic of chronic diseases. Cardiovascular disease and depression carry a large burden of disease and often occur together. Poor dietary patterns have been identified as an independent risk factor for depression while healthy diets with minimally processed food are protective. Traditional Mediterranean diets have been shown to reduce risk of cardiovascular disease; however there is a need for clinical trials in people with depression. This paper reports the study protocol of a Mediterranean-style diet intervention conducted in adults with self-reported depression. Methods/design: HELFIMED is a parallel 6-month randomised controlled trial investigating whether dietary patterns can be improved in people with depressive symptoms and whether healthier diet combined with fish oil supplementation can improve mental and cardiometabolic health and quality of life. Adults aged 18-65 years with self-reported depressive symptoms over the previous two months (N = 163) were block-randomised on age and gender between May 2014 and June 2015 to receive nutrition education, food hampers, fortnightly cooking workshops based on Mediterranean-style dietary principles for 3 months and fish oil supplementation for 6 months, or to attend fortnightly social groups (control group) for 3 months. All participants completed mental health (DASS and PANAS), quality of life, dietary and shopping and budgeting questionnaires and provided anthropometric measurements, blood and urine samples at baseline, 3 and 6 months. Additionally the treatment group attended focus groups at 3 and 6 months. Primary and secondary outcomes will be analysed using linear mixed modelling and correlations will investigate associations between improved health outcomes and subjective/objective measures of improved diet/nutritional status. Discussion: This study will contribute causal evidence to prior observational and longitudinal studies that have shown associations between Mediterranean diet and mental health. The results will inform public health and clinical strategies for treatment of depression and comorbid cardiometabolic risk factors.Trial registration: Australian New Zealand Clinical Trials Register (ACTRN12614000438651). Trial registration date: 23rd April 2014. Refereed/Peer-reviewed
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.